心脏衰竭中的贫血和铁缺乏症:当前的概念和新兴疗法
Inder S Anand1,2,3, Pankaj Gupta4,3
1VA Medical Center, Minneapolis, MN (I.A., P.G.) anand001@umn.edu.
Circulation
|July 4, 2018
概括
贫血和铁缺乏症在心力衰竭患者中很常见,影响了结果. 静脉注射铁可以改善症状和运动能力,但长期的安全性和有效性需要进一步研究.
科学领域:
- 心脏病学
- 血液学
背景情况:
- 贫血和缺铁是心力衰竭患者常见的并发症.
- 这些情况与较差的临床状态和不良结果有关.
- 贫血和铁缺乏在心力衰竭进展中的确切作用仍在研究中.
研究的目的:
- 审查心力衰竭中贫血和铁缺乏症的原因,病变和治疗选择.
- 讨论当前对心力衰竭患者缺铁治疗的理解.
主要方法:
- 对心力衰竭中的贫血和缺铁现有文献的审查.
- 分析评估治疗策略的研究,包括红色形成刺激剂和静脉注射铁.
主要成果:
- 刺激红细胞形成的药物未能改善心力衰竭患者的治疗结果,并带有风险.
- 在小型研究中,静脉注射铁有望改善症状和运动能力,但缺乏长期数据.
- 区分绝对缺铁和功能缺铁对于治疗决定至关重要.
结论:
- 贫血和缺铁严重影响心力衰竭患者.
- 虽然不建议使用红细胞形成刺激剂,但静脉注射铁有助于治疗症状.
- 需要进一步研究以确定铁补充剂在心力衰竭中的长期安全性和有效性.
相关概念视频
Heart Failure VI: Adjunct Therapies
368
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
368
Heart Failure II: Pathophysiology
975
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
975
Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction
924
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
924
Heart Failure Drugs: Diuretics
990
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
990
Heart Failure V: Medical Management
342
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
342


